Sun Infringes Orexo's Opioid Addiction Drug IP, Judge Rules
A New Jersey federal judge has sided with drugmaker Orexo in a patent suit lodged against competitor Sun Pharmaceuticals over generic versions of opioid addiction treatment Zubsolv, upholding the asserted biotechnology...To view the full article, register now.
Already a subscriber? Click here to view full article